Orthofix Medical (OFIX) Equity Average (2011 - 2026)

Orthofix Medical has disclosed Equity Average across 16 years of filings, most recently posting $442.6 million for Q1 2026.

• Quarterly Equity Average fell 7.93% year-over-year to $442.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $442.6 million (down 7.93% YoY) and the FY2025 annual result came in at $476.6 million, down 13.49% from the prior year.
• Equity Average fell to $442.6 million in Q1 2026, from $446.3 million in the prior quarter.
• Over five years, Equity Average peaked at $652.1 million in Q2 2023 and troughed at $335.2 million in Q4 2022.
• A 5-year average of $482.8 million and a median of $480.7 million in 2025 frame the typical range for Equity Average.
• Annual changes were most pronounced in 2023 — Equity Average surged 92.49% — and 2025, when it dropped 17.89%.
• Tracing OFIX's Equity Average over 5 years: stood at $335.2 million in 2022, then soared by 81.12% to $607.1 million in 2023, then declined by 15.25% to $514.5 million in 2024, then slipped by 13.27% to $446.3 million in 2025, then slipped by 0.82% to $442.6 million in 2026.
• Business Quant data shows OFIX's Equity Average at $442.6 million in Q1 2026, $446.3 million in Q4 2025, and $450.4 million in Q3 2025.